Pfizer withdraws application for emergency use of vaccine in India

Pfizer Inc has withdrawn an application for emergency-use authorisation of its Covid-19 vaccine in India that it has developed with Germany’s BioNTech, the company told Reuters on Friday.

Pfizer had sought authorisation for its vaccine in India late last year, but the government in January approved two much cheaper shots — one from Oxford University/AstraZeneca and another developed at home by Bharat Biotech with the Indian Council of Medical Research. Both companies had applied for approval of their vaccines after Pfizer.


Khaleej Times

Related Articles

Back to top button